DK0914119T3 - Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan - Google Patents

Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan

Info

Publication number: DK0914119T3
Authority: DK; Denmark
Prior art keywords: valsartan; preparation; dosage forms; oral dosage; solid oral
Prior art date: 1996-06-27

Application number

DK97929209T

Other languages

English (en)

Inventor

Robert Frank Wagner

Yoshimitsu Katakuse

Takashi Taike

Fujiki Yamato

Manfred Kohlmeyer

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-27

Filing date

1997-06-18

Publication date

2005-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795969&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0914119(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-06-18 Application filed by Novartis Ag filed Critical Novartis Ag

2005-01-31 Application granted granted Critical

2005-01-31 Publication of DK0914119T3 publication Critical patent/DK0914119T3/da

Links

239000004072 C09CA03 - Valsartan Substances 0.000 title 1
239000006186 oral dosage form Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1
SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title 1
229960004699 valsartan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK97929209T 1996-06-27 1997-06-18 Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan DK0914119T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9613470.5A GB9613470D0 (en)	1996-06-27	1996-06-27	Small solid oral dosage form
PCT/EP1997/003172 WO1997049394A2 (en)	1996-06-27	1997-06-18	Sold oral dosage forms of valsartan

Publications (1)

Publication Number	Publication Date
DK0914119T3 true DK0914119T3 (da)	2005-01-31

Family

ID=10795969

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK03027840T DK1410797T3 (da)	1996-06-27	1997-06-18	Faste orale dosisformer indeholdende valsartan
DK06126819.9T DK1767206T3 (da)	1996-06-27	1997-06-18	Faste orale doseringsformer indeholdende valsartan og hydrochlorhiazid
DK97929209T DK0914119T3 (da)	1996-06-27	1997-06-18	Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK03027840T DK1410797T3 (da)	1996-06-27	1997-06-18	Faste orale dosisformer indeholdende valsartan
DK06126819.9T DK1767206T3 (da)	1996-06-27	1997-06-18	Faste orale doseringsformer indeholdende valsartan og hydrochlorhiazid

Country Status (33)

Country	Link
US (3)	US6294197B1 (da)
EP (7)	EP1767207A3 (da)
JP (5)	JP2000506540A (da)
KR (6)	KR101208430B1 (da)
CN (3)	CN1951372B (da)
AR (2)	AR008618A1 (da)
AT (3)	ATE276750T1 (da)
BR (1)	BR9709956A (da)
CA (2)	CA2673462C (da)
CO (1)	CO4870755A1 (da)
CY (1)	CY2553B1 (da)
CZ (1)	CZ296850B6 (da)
DE (3)	DE69730834T2 (da)
DK (3)	DK1410797T3 (da)
ES (3)	ES2335683T3 (da)
GB (1)	GB9613470D0 (da)
HK (2)	HK1019858A1 (da)
HU (1)	HU229134B1 (da)
ID (1)	ID17553A (da)
IL (2)	IL127564A0 (da)
MY (3)	MY146868A (da)
NO (2)	NO317181B1 (da)
NZ (2)	NZ333385A (da)
PE (1)	PE87498A1 (da)
PL (2)	PL188271B1 (da)
PT (3)	PT1767206E (da)
RU (5)	RU2203054C2 (da)
SI (2)	SI1410797T1 (da)
SK (1)	SK285902B6 (da)
TR (1)	TR199802698T2 (da)
TW (1)	TW473394B (da)
WO (1)	WO1997049394A2 (da)
ZA (1)	ZA975673B (da)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
US20030045561A1 (en) *	2001-02-06	2003-03-06	Smithkline Beecham Corporation	Method of treating isolated systolic hypertension
BR9908474A (pt) *	1998-03-04	2000-12-05	Takeda Chemical Industries Ltd	Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
ES2274625T3 (es)	1998-05-18	2007-05-16	Takeda Pharmaceutical Company Limited	Comprimidos desintegrables en la boca que comprenden un bencimidazol.
SG142116A1 (en) *	1998-07-10	2008-05-28	Novartis Ag	Antihypersensitive combination of valsartan and calcium channel blocker
CZ297795B6 (cs)	1998-12-23	2007-03-28	Novartis Ag	Tablety obsahující valsartan
BR0007686A (pt) *	1999-01-26	2001-11-06	Novartis Ag	Uso de antagonistas receptores da angiotensina ii para tratar enfartação miocárdia aguda
CN101011390A (zh)	1999-01-26	2007-08-08	诺瓦提斯公司	血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
WO2001013900A2 (en) *	1999-08-24	2001-03-01	Medicure International Inc.	Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
DE10066408B4 (de) *	2000-03-24	2010-03-18	3M Espe Dental Ag	Verwendung feinkörniger Pulver für supragingivales Pulverstrahlen
CA2311734C (en) *	2000-04-12	2011-03-08	Bristol-Myers Squibb Company	Flash-melt oral dosage formulation
WO2001097805A2 (en)	2000-06-22	2001-12-27	Novartis Ag	Solid valsartan pharmaceutical compositions
AU2005200815B2 (en) *	2000-06-22	2008-01-17	Novartis Ag	Solid valsartan pharmaceutical compositions
US20020132839A1 (en) *	2000-06-22	2002-09-19	Ganter Sabina Maria	Tablet formulations comprising valsartan
PL205715B1 (pl)	2000-07-19	2010-05-31	Novartis Ag	Sól wapniowa walsartanu w postaci tetrahydratu, preparat farmaceutyczny zawierający tę sól, zastosowanie i sposób wytwarzania tej soli
PE20020617A1 (es) *	2000-08-22	2002-08-05	Novartis Ag	Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
US20060089389A1 (en)	2000-08-22	2006-04-27	Malcolm Allison	Combination
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2003013609A1 (en) *	2001-08-03	2003-02-20	Takeda Chemical Industries, Ltd.	Sustained-release medicines
GB0209265D0 (en) *	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
EG24716A (en)	2002-05-17	2010-06-07	Novartis Ag	Combination of organic compounds
DE10230272A1 (de) *	2002-07-05	2004-01-22	Solvay Pharmaceuticals Gmbh	AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen
EP1382334A1 (en) *	2002-07-11	2004-01-21	Université de Picardie Jules Verne	Use of angiotensin II AT1-receptor blockers (ARB), alone or combined with thiazide or angiotensin II for the treatment of stroke
DE602004013405T2 (de) *	2003-03-17	2009-05-07	Teva Pharmaceutical Industries Ltd.	Polymorphe formen von valsartan
EP1950204A1 (en)	2003-03-17	2008-07-30	Teva Pharmaceutical Industries Ltd.	Amorphous form of valsartan
US7199144B2 (en) *	2003-04-21	2007-04-03	Teva Pharmaceuticals Industries, Ltd.	Process for the preparation of valsartan and intermediates thereof
WO2004094392A1 (en) *	2003-04-21	2004-11-04	Teva Pharmaceutical Industries Ltd.	Process for the preparation of valsartan
WO2004094391A2 (en) *	2003-04-21	2004-11-04	Teva Pharmaceutical Industries Ltd.	Process for the preparation of valsartan and intermediates thereof
JP4505859B2 (ja) *	2003-08-08	2010-07-21	味の素株式会社	ナテグリニド含有製剤
GB0325605D0 (en) *	2003-11-03	2003-12-10	Novartis Ag	Combination of organic compounds
EP1680095A2 (en) *	2003-11-03	2006-07-19	Zentiva, a.s.	Valsartan containing formulation
JP2005187793A (ja) *	2003-12-24	2005-07-14	Rohm & Haas Electronic Materials Llc	改良された接着剤
WO2005082329A2 (en) *	2004-02-19	2005-09-09	Ranbaxy Laboratories Limited	Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
WO2005089720A1 (en) *	2004-03-10	2005-09-29	Ranbaxy Laboratories Limited	Valsartan tablets and the process for the preparation thereof
US7528258B2 (en)	2004-09-02	2009-05-05	Teva Pharmaceutical Industries Ltd	Preparation of olmesartan medoxomil
EP2801354B1 (en)	2004-10-08	2017-02-08	Forward Pharma A/S	Controlled release pharmaceutical compositions comprising a fumaric acid ester
US20080050605A1 (en) *	2004-10-15	2008-02-28	Rapp Knut M	Pan Coating Process
EP1674080A1 (en) *	2004-12-24	2006-06-28	KRKA, D.D., Novo Mesto	Solid pharmaceutical composition comprising valsartan
EA015108B1 (ru) *	2004-12-24	2011-06-30	КРКА, д.д., НОВО МЕСТО	Способ получения твердой фармацевтической композиции, содержащей валсартан
FR2882260A1 (fr) *	2005-02-21	2006-08-25	Flamel Technologies Sa	Forme pharmaceutique orale multimicroparticulaire a liberation modifiee d'antagonistes des recepteurs de l'angiotensine ii
AP2896A (en) *	2005-05-31	2014-05-31	Mylan Lab Inc	Compositions comprising nebivolol
US20070117987A1 (en) *	2005-07-05	2007-05-24	Viviana Braude	Process for preparing valsartan
GB0513888D0 (en) *	2005-07-06	2005-08-10	Btg Int Ltd	Core 2 GLCNAC-T Inhibitors II
US20080227836A1 (en) *	2005-10-31	2008-09-18	Lupin Ltd	Stable Solid Oral Dosage Forms of Valsartan
RU2309732C1 (ru)	2006-03-13	2007-11-10	Олег Ильич Эпштейн	Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US20100029654A1 (en) *	2006-03-23	2010-02-04	Mount Sinai School Of Medicine	Cardiovascular compositions and use of the same for the treatment of alzheimer's disease
CA2654408C (en)	2006-06-06	2018-05-08	Oleg Iliich Epshtein	Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
EP2043607A2 (en) *	2006-06-23	2009-04-08	Usv Limited	Process for the preparation of micronized valsartan
GB0612540D0 (en)	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
CN101534798B (zh) *	2006-10-30	2012-02-15	韩诺生物制约株式会社	包含噻嗪类和血管紧张素ⅱ受体阻断剂的控释药物组合物
WO2008064338A2 (en) *	2006-11-22	2008-05-29	Rubicon Research Pvt. Ltd.	Valsartan formulation for pulsatile delivery
EP2139473A1 (en) *	2007-03-29	2010-01-06	Alembic Limited	Valsartan tablet formulations
TR200703568A1 (tr)	2007-05-24	2008-07-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Valsartan formülasyonları
ES2686081T3 (es) *	2007-07-31	2018-10-16	Cargill, Incorporated	Dextrosa comprimible directamente
GB0715628D0 (en) *	2007-08-10	2007-09-19	Generics Uk Ltd	Solid valsartan composition
CN101396366B (zh) *	2007-09-25	2010-10-13	浙江华海药业股份有限公司	含缬沙坦的固体口服制剂及其制备方法
US20100209480A1 (en) *	2007-09-28	2010-08-19	Ralf Altenburger	Galenical formulations of organic compounds
KR20100091963A (ko)	2007-10-09	2010-08-19	노파르티스 아게	발사르탄의 제약적 제형
ES2536514T3 (es)	2007-11-06	2015-05-26	Novartis Ag	Composiciones farmacéuticas de doble acción basadas en superestructuras de antagonista/bloqueador de receptores de angiotensina (ARB) y receptor de endopeptidasa neutra (NEP)
EP2067470A1 (en) *	2007-12-03	2009-06-10	Laboratorios Lesvi, S.L.	Pharmaceutical compositions containing valsartan and process for its preparation
EP2240163A1 (en) *	2007-12-31	2010-10-20	Lupin Limited	Pharmaceutical compositions of amlodipine and valsartan
RU2010139567A (ru) *	2008-02-28	2012-04-10	Новартис АГ (CH)	Содержащие валсартан твердые оральные лекарственные формы и способы их изготовления
US20090226515A1 (en) *	2008-03-04	2009-09-10	Pharma Pass Ii Llc	Statin compositions
US20090226516A1 (en) *	2008-03-04	2009-09-10	Pharma Pass Ii Llc	Sartan compositions
KR101209319B1 (ko) *	2008-04-29	2012-12-06	한올바이오파마주식회사	안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
AU2009257174A1 (en) *	2008-06-09	2009-12-17	Dimerix Bioscience Pty Ltd	Novel receptor hetero-dimers/-oligomers
KR101033975B1 (ko) *	2008-10-10	2011-05-11	이희엽	직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형
DE102008051783A1 (de) *	2008-10-17	2010-04-22	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Valsartan enthaltende Tablette
WO2010075347A2 (en)	2008-12-23	2010-07-01	Takeda Pharmaceutical Company Limited	Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
EP2405899A2 (en)	2009-03-11	2012-01-18	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
KR101084783B1 (ko) *	2009-09-01	2011-11-22	삼성에스디아이 주식회사	이차 전지 및 그의 제조 방법
WO2011027021A1 (en) *	2009-09-01	2011-03-10	Orion Corporation	A method for the treatment of hypertension
ES2364011B1 (es)	2009-11-20	2013-01-24	Gp Pharm, S.A.	Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN101897675B (zh) *	2010-02-10	2012-11-21	温士顿医药股份有限公司	含有凡尔沙坦或其药学上可接受的盐的固体剂型口服医药组成物
WO2011102702A2 (en)	2010-02-16	2011-08-25	Krka, D. D., Novo Mesto	Process for the preparation of oral solid dosage forms comprising valsartan
AR083417A1 (es)	2010-10-14	2013-02-21	Novartis Ag	Composiciones farmaceuticas que contienen un dgat1 inhibidor
JP5882796B2 (ja)	2011-03-31	2016-03-09	キヤノン株式会社	振動体の駆動方法、振動装置、該振動装置を有する駆動装置、及び光学機器
GB201116993D0 (en) *	2011-10-03	2011-11-16	Ems Sa	Pharmaceutical compositions of antihypertensives
JP2015504878A (ja)	2011-12-26	2015-02-16	ノバルティスアーゲー	錠剤及び有核剤
WO2013098578A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
WO2013098576A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan
JP6018420B2 (ja) *	2012-06-05	2016-11-02	ニプロ株式会社	アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物
WO2014038895A1 (ko) *	2012-09-06	2014-03-13	한국콜마주식회사	발사르탄 함유 고형 경구제형 및 그 제조방법
JP2014062064A (ja) *	2012-09-21	2014-04-10	Ohara Yakuhin Kogyo Kk	バルサルタン含有錠剤の製造方法
JP6238831B2 (ja) *	2014-04-25	2017-11-29	沢井製薬株式会社	バルサルタン含有錠剤及びその製造方法
JP6141472B2 (ja) *	2016-03-02	2017-06-07	大原薬品工業株式会社	バルサルタン含有錠剤の製造方法
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
US11081240B2 (en)	2018-06-14	2021-08-03	Astrazeneca Uk Limited	Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition
EP4295839A1 (en)	2022-06-20	2023-12-27	KRKA, d.d., Novo mesto	Combination of valsartan and indapamide

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3200039A (en)	1962-05-28	1965-08-10	Pfizer & Co C	Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
GB1422176A (en)	1973-05-05	1976-01-21	Beecham Group Ltd	Pharmaceutical tablets
AU528098B2 (en)	1978-11-16	1983-04-14	Beecham Group Plc	Analgesic tablet
US4353887A (en)	1979-08-16	1982-10-12	Ciba-Geigy Corporation	Divisible tablet having controlled and delayed release of the active substance
US4238485A (en) *	1979-10-29	1980-12-09	Merck & Co., Inc.	Novel pharmaceutical compositions
EP0070127A3 (en)	1981-07-10	1983-08-17	Beecham Group Plc	Tablets
US4543359A (en) *	1982-10-01	1985-09-24	Eaton Laboratories, Inc.	Treating cardiac arrhythmias with dantrolene sodium
HU187215B (en) *	1983-01-26	1985-11-28	Egyt Gyogyszervegyeszeti Gyar	Method for producing pharmaceutical product of high actor content and prolonged effect
US4609675A (en) *	1984-08-17	1986-09-02	The Upjohn Company	Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4743612A (en) *	1986-10-17	1988-05-10	Berlex Laboratories, Inc.	Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure
DE3705055A1 (de) *	1987-02-18	1988-09-01	Boehringer Ingelheim Kg	Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit
JP2518854B2 (ja) *	1987-06-19	1996-07-31	旭化成工業株式会社	固形製剤の製法
DE3739779A1 (de) *	1987-11-24	1989-06-08	Beiersdorf Ag	Pharmazeutische praeparate
SE506179C2 (sv) *	1989-01-23	1997-11-17	Ciba Geigy Ag	Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum
GB8909793D0 (en)	1989-04-28	1989-06-14	Beecham Group Plc	Pharmaceutical formulation
DK0443983T3 (da)	1990-02-19	1996-03-18	Ciba Geigy Ag	Acrylforbindelser
CA2092565A1 (en) *	1990-09-28	1992-03-29	Robert T. Sims	Ibuprofen-diuretic combinations
JP3069458B2 (ja) *	1992-01-29	2000-07-24	武田薬品工業株式会社	口腔内崩壊型錠剤およびその製造法
IL104755A0 (en)	1992-02-17	1993-06-10	Ciba Geigy Ag	Treatment of glaucoma
US5395627A (en) *	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
AU5449194A (en)	1992-10-26	1994-05-24	Merck & Co., Inc.	Combinations of angiotensin-ii receptor antagonists and diuretics
WO1994015643A1 (en)	1992-12-30	1994-07-21	Fmc Corporation	Readily available konjac glucomannan sustained release excipient
JP3057471B2 (ja) *	1993-06-07	2000-06-26	武田薬品工業株式会社	アンジオテンシンｉｉ介在性諸疾患の予防または治療剤
US5464854A (en)	1993-11-11	1995-11-07	Depadova; Anathony S.	Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S.
AT401871B (de) *	1994-01-28	1996-12-27	Gebro Broschek Gmbh	Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
JP3534130B2 (ja) *	1994-03-01	2004-06-07	旭化成ケミカルズ株式会社	医薬品組成物
GB9404010D0 (en) *	1994-03-02	1994-04-20	Opt Tel Services Limited	Telephone dialling monitoring and route selecting apparatus
SK117996A3 (en) *	1994-03-17	1997-03-05	Ciba Geigy Ag	Pharmaceutical composition for treatment of diabetic nephropathy
GB9408117D0 (en)	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DE19502065C2 (de) *	1995-01-14	1996-05-02	Prophyta Biolog Pflanzenschutz	Pilzisolat mit fungizider Wirkung
US5994348A (en) *	1995-06-07	1999-11-30	Sanofi	Pharmaceutical compositions containing irbesartan
FR2735365B1 (fr) *	1995-06-14	1997-09-05	Sanofi Sa	Utilisation d'un antagoniste de l'angiotensine ii et d'un derive du benzofurane pour la preparation d'un medicament utile dans le traitement des affections cardiovasculaires
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
JP2011123241A (ja) *	2009-12-10	2011-06-23	Canon Inc	撮影システム

1996
- 1996-06-27 GB GBGB9613470.5A patent/GB9613470D0/en active Pending
1997
- 1997-06-14 MY MYPI20041863A patent/MY146868A/en unknown
- 1997-06-14 MY MYPI97002679A patent/MY123149A/en unknown
- 1997-06-14 MY MYPI20093392A patent/MY156312A/en unknown
- 1997-06-18 BR BR9709956A patent/BR9709956A/pt not_active Application Discontinuation
- 1997-06-18 DE DE69730834T patent/DE69730834T2/de not_active Expired - Lifetime
- 1997-06-18 KR KR1020117011286A patent/KR101208430B1/ko not_active IP Right Cessation
- 1997-06-18 ES ES06126819T patent/ES2335683T3/es not_active Expired - Lifetime
- 1997-06-18 SI SI9730773T patent/SI1410797T1/sl unknown
- 1997-06-18 CN CN2006100999105A patent/CN1951372B/zh not_active Expired - Lifetime
- 1997-06-18 PT PT06126819T patent/PT1767206E/pt unknown
- 1997-06-18 CA CA2673462A patent/CA2673462C/en not_active Expired - Fee Related
- 1997-06-18 JP JP10502269A patent/JP2000506540A/ja active Pending
- 1997-06-18 PL PL97363524A patent/PL188271B1/pl unknown
- 1997-06-18 SK SK1784-98A patent/SK285902B6/sk not_active IP Right Cessation
- 1997-06-18 CZ CZ0426998A patent/CZ296850B6/cs not_active IP Right Cessation
- 1997-06-18 US US09/202,805 patent/US6294197B1/en not_active Expired - Lifetime
- 1997-06-18 PT PT97929209T patent/PT914119E/pt unknown
- 1997-06-18 CA CA002259148A patent/CA2259148C/en not_active Expired - Fee Related
- 1997-06-18 KR KR1019980710521A patent/KR100618038B1/ko not_active IP Right Cessation
- 1997-06-18 KR KR1020087000538A patent/KR20080014149A/ko active Search and Examination
- 1997-06-18 DE DE69739642T patent/DE69739642D1/de not_active Expired - Lifetime
- 1997-06-18 HU HU0203374A patent/HU229134B1/hu not_active IP Right Cessation
- 1997-06-18 DE DE69738089T patent/DE69738089T2/de not_active Expired - Lifetime
- 1997-06-18 KR KR1020067011260A patent/KR20060079260A/ko not_active Application Discontinuation
- 1997-06-18 WO PCT/EP1997/003172 patent/WO1997049394A2/en active Search and Examination
- 1997-06-18 DK DK03027840T patent/DK1410797T3/da active
- 1997-06-18 EP EP06126838A patent/EP1767207A3/en not_active Withdrawn
- 1997-06-18 CN CN031466788A patent/CN1475207B/zh not_active Expired - Lifetime
- 1997-06-18 ES ES03027840T patent/ES2290400T3/es not_active Expired - Lifetime
- 1997-06-18 RU RU99101056/14A patent/RU2203054C2/ru active IP Right Maintenance
- 1997-06-18 NZ NZ333385A patent/NZ333385A/xx not_active IP Right Cessation
- 1997-06-18 DK DK06126819.9T patent/DK1767206T3/da active
- 1997-06-18 EP EP06126829A patent/EP1774967A1/en not_active Withdrawn
- 1997-06-18 EP EP97929209A patent/EP0914119B1/en not_active Expired - Lifetime
- 1997-06-18 EP EP09001681A patent/EP2055301A1/en not_active Withdrawn
- 1997-06-18 IL IL12756497A patent/IL127564A0/xx unknown
- 1997-06-18 KR KR1020097017936A patent/KR101161283B1/ko not_active IP Right Cessation
- 1997-06-18 CN CNB971958912A patent/CN1133427C/zh not_active Expired - Lifetime
- 1997-06-18 EP EP03027840A patent/EP1410797B1/en not_active Revoked
- 1997-06-18 PL PL97330709A patent/PL188233B1/pl not_active IP Right Cessation
- 1997-06-18 EP EP06126834A patent/EP1776953A1/en not_active Withdrawn
- 1997-06-18 DK DK97929209T patent/DK0914119T3/da active
- 1997-06-18 SI SI9730686T patent/SI0914119T1/xx unknown
- 1997-06-18 KR KR1020057015071A patent/KR100792389B1/ko not_active IP Right Cessation
- 1997-06-18 EP EP06126819A patent/EP1767206B1/en not_active Revoked
- 1997-06-18 AT AT97929209T patent/ATE276750T1/de active
- 1997-06-18 AT AT06126819T patent/ATE446749T1/de active
- 1997-06-18 TR TR1998/02698T patent/TR199802698T2/xx unknown
- 1997-06-18 PT PT03027840T patent/PT1410797E/pt unknown
- 1997-06-18 RU RU99101056/63D patent/RU2294743C2/ru not_active IP Right Cessation
- 1997-06-18 AT AT03027840T patent/ATE371449T1/de active
- 1997-06-18 ES ES97929209T patent/ES2231873T3/es not_active Expired - Lifetime
- 1997-06-23 CO CO97034775A patent/CO4870755A1/es unknown
- 1997-06-24 PE PE1997000539A patent/PE87498A1/es not_active IP Right Cessation
- 1997-06-25 AR ARP970102790A patent/AR008618A1/es active IP Right Grant
- 1997-06-26 ZA ZA9705673A patent/ZA975673B/xx unknown
- 1997-06-26 ID IDP972207A patent/ID17553A/id unknown
- 1997-09-09 TW TW086113018A patent/TW473394B/zh not_active IP Right Cessation
1998
- 1998-12-22 NO NO19986056A patent/NO317181B1/no not_active IP Right Cessation
1999
- 1999-11-09 HK HK99105148A patent/HK1019858A1/xx not_active IP Right Cessation
2001
- 2001-08-01 US US09/920,159 patent/US6485745B1/en not_active Expired - Fee Related
2002
- 2002-09-20 US US10/251,009 patent/US6858228B2/en not_active Expired - Fee Related
2003
- 2003-01-23 JP JP2003014987A patent/JP2003231634A/ja not_active Withdrawn
- 2003-02-21 NZ NZ524346A patent/NZ524346A/en not_active IP Right Cessation
2004
- 2004-03-26 NO NO20041287A patent/NO331739B1/no not_active IP Right Cessation
- 2004-05-25 HK HK04103718.1A patent/HK1060700A1/xx not_active IP Right Cessation
2006
- 2006-03-21 CY CY0600007A patent/CY2553B1/xx unknown
2007
- 2007-01-10 RU RU2007100200/15A patent/RU2453306C2/ru not_active IP Right Cessation
- 2007-02-06 AR ARP070100474A patent/AR059324A2/es not_active Application Discontinuation
- 2007-06-28 JP JP2007170267A patent/JP4969338B2/ja not_active Expired - Lifetime
2008
- 2008-11-17 IL IL195339A patent/IL195339A0/en unknown
2009
- 2009-04-27 RU RU2009115778/15A patent/RU2009115778A/ru unknown
2011
- 2011-12-09 JP JP2011270429A patent/JP2012051948A/ja not_active Withdrawn
2013
- 2013-03-26 RU RU2013113610/15A patent/RU2013113610A/ru not_active Application Discontinuation
- 2013-10-25 JP JP2013221985A patent/JP2014012747A/ja active Pending

Also Published As

Publication number	Publication date
HUP0203374A3 (en)	2004-06-28
DE69730834D1 (de)	2004-10-28
KR100792389B1 (ko)	2008-01-08
IL195339A0 (en)	2009-08-03
BR9709956A (pt)	1999-08-10
JP2014012747A (ja)	2014-01-23
NO20041287L (no)	2004-03-26
NO986056L (no)	1998-12-22
EP1410797A1 (en)	2004-04-21
US6485745B1 (en)	2002-11-26
KR20090099020A (ko)	2009-09-18
PL330709A1 (en)	1999-05-24
CN1475207B (zh)	2010-09-29
SK285902B6 (sk)	2007-10-04
CZ296850B6 (cs)	2006-07-12
NZ524346A (en)	2004-09-24
EP1767206B1 (en)	2009-10-28
DE69738089D1 (de)	2007-10-11
HK1060700A1 (en)	2004-08-20
CZ426998A3 (cs)	1999-03-17
CN1232394A (zh)	1999-10-20
JP2000506540A (ja)	2000-05-30
HU229134B1 (en)	2013-08-28
CN1475207A (zh)	2004-02-18
AR059324A2 (es)	2008-03-26
NZ333385A (en)	2000-09-29
EP1774967A1 (en)	2007-04-18
DK1767206T3 (da)	2010-01-25
AR008618A1 (es)	2000-02-09
CA2259148A1 (en)	1997-12-31
TR199802698T2 (xx)	1999-04-21
PT1410797E (pt)	2007-12-03
EP1767207A2 (en)	2007-03-28
KR20110063587A (ko)	2011-06-10
DK1410797T3 (da)	2007-10-15
GB9613470D0 (en)	1996-08-28
EP0914119B1 (en)	2004-09-22
TW473394B (en)	2002-01-21
KR101208430B1 (ko)	2012-12-05
WO1997049394A2 (en)	1997-12-31
RU2013113610A (ru)	2014-10-10
EP1767206A3 (en)	2007-04-18
CN1951372A (zh)	2007-04-25
DE69730834T2 (de)	2005-10-06
NO331739B1 (no)	2012-03-12
JP4969338B2 (ja)	2012-07-04
JP2003231634A (ja)	2003-08-19
WO1997049394A3 (en)	2001-12-20
PT1767206E (pt)	2010-01-27
ATE371449T1 (de)	2007-09-15
NO317181B1 (no)	2004-09-06
US6858228B2 (en)	2005-02-22
ATE276750T1 (de)	2004-10-15
CA2673462A1 (en)	1997-12-31
MY156312A (en)	2016-01-29
PL188233B1 (pl)	2004-12-31
HUP0203374A2 (hu)	2004-05-28
US6294197B1 (en)	2001-09-25
RU2007100200A (ru)	2008-07-20
DE69738089T2 (de)	2008-05-21
ES2335683T3 (es)	2010-03-31
EP0914119A3 (en)	2002-03-06
KR20050092054A (ko)	2005-09-16
AU724998B2 (en)	2000-10-05
EP2055301A1 (en)	2009-05-06
ES2231873T3 (es)	2005-05-16
KR20080014149A (ko)	2008-02-13
SI1410797T1 (sl)	2008-08-31
RU2009115778A (ru)	2010-11-10
JP2007238637A (ja)	2007-09-20
KR20060079260A (ko)	2006-07-05
CN1133427C (zh)	2004-01-07
EP1410797B1 (en)	2007-08-29
JP2012051948A (ja)	2012-03-15
DE69739642D1 (de)	2009-12-10
EP1767207A3 (en)	2007-04-18
RU2294743C2 (ru)	2007-03-10
KR20000022111A (ko)	2000-04-25
PL188271B1 (pl)	2005-01-31
IL127564A0 (en)	1999-10-28
EP1776953A1 (en)	2007-04-25
KR100618038B1 (ko)	2006-11-30
SK178498A3 (en)	1999-06-11
ATE446749T1 (de)	2009-11-15
EP1767206A2 (en)	2007-03-28
ID17553A (id)	1998-01-08
US20030035832A1 (en)	2003-02-20
RU2203054C2 (ru)	2003-04-27
CA2259148C (en)	2009-09-29
PT914119E (pt)	2005-02-28
AU3340297A (en)	1998-01-14
CO4870755A1 (es)	1999-12-27
CY2553B1 (en)	2008-07-02
ZA975673B (en)	1997-12-29
CN1951372B (zh)	2011-03-23
MY123149A (en)	2006-05-31
NO986056D0 (no)	1998-12-22
EP0914119A2 (en)	1999-05-12
ES2290400T3 (es)	2008-02-16
SI0914119T1 (en)	2005-04-30
PE87498A1 (es)	1998-12-21
HK1019858A1 (en)	2000-06-09
KR101161283B1 (ko)	2012-07-02
MY146868A (en)	2012-09-28
RU2453306C2 (ru)	2012-06-20
CA2673462C (en)	2011-10-04

Publication	Publication Date	Title
DK0914119T3 (da)	2005-01-31	Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
DK1275387T3 (da)	2006-08-28	Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK0770615T3 (da)	2003-07-14	Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
FI972945A (fi)	1997-07-11	Antigeenien antamiseen soveltuvia koostumuksia
DE59506139D1 (de)	1999-07-15	Orale Retard-Präparation
DK0746310T3 (da)	1999-08-02	Præparat med styret afgivelse
DK0775100T3 (da)	2000-11-27	Fremgangsmåde til fremstilling af trifluorethylen
DK0768310T3 (da)	2000-04-17	Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0877738T3 (da)	2003-09-08	Fremgangsmåde til fremstilling af phenylimidazolidinderivater
TR199800403A3 (tr)	1998-09-21	a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
DK0735043T3 (da)	1998-10-07	Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
NO996432L (no)	2000-02-09	Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
TR199800068A3 (tr)	1998-08-21	Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
DK0721929T3 (da)	2000-03-27	Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
DK1012152T3 (da)	2003-02-10	Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0782982T3 (da)	2000-10-09	Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater
DK0863874T3 (da)	2001-01-29	Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
NO20013219L (no)	1998-11-26	Fremgangsmåte for fremstilling av trinatrium-pentacyanoamino- ferrat (II)
NO961429D0 (no)	1996-04-11	Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO20003077D0 (no)	2000-06-15	FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20013044D0 (no)	2001-06-19	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
DK1012143T3 (da)	2004-04-19	Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
DK1080076T3 (da)	2004-03-22	Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater
NO994557D0 (no)	1999-09-20	Fremgangsmaate for fremstilling av arylaminotriazolopyridiner